Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03030261
Brief Title: Elotuzumab, Pomalidomide, & Dexamethasone (Elo-Pom-Dex) With Second Autologous Stem Cell Transplantation for Relapsed Multiple Myeloma

First Submitted : January 18, 2017
First Submitted that Met QC Criteria : January 20, 2017
First Posted : January 24, 2017 (Estimate)

Last Update Submitted that Met QC Criteria : January 18, 2021
Last Update Posted : January 22, 2021